CEO Marshall Perkins将他在MDCE的股份提升到66.2M股, CEO Marshall Perkins boosted his stake in MDCE to 66.2M shares via open-market buys at $0.0002, affirming confidence in the company’s AI medical screening strategy.

医疗技术公司首席执行官Marshall Perkins通过个人公开市场采购,每股0.002美元,将所有权提高到66 199 283股,没有发行新股。 CEO Marshall Perkins of Medical Care Technologies Inc. (MDCE) increased his ownership to 66,199,283 shares through personal open-market purchases at $0.0002 per share, with no new shares issued. 此前他曾将近20亿的成熟股份归还国库,以防止稀释。 The move follows his prior return of nearly 2 billion matured shares to treasury to prevent dilution. 该公司的未偿股份数仍为33.9亿。 The company’s outstanding share count remains at 3.39 billion. Perkins表示对该公司AI驱动的医学预检战略和计划继续根据市场和监管条件购买股份的信心。 Perkins expressed ongoing confidence in the firm’s AI-driven medical pre-screening strategy and plans to continue buying shares subject to market and regulatory conditions.